Adtran price target raised to $15 from $10 at Rosenblatt

Rosenblatt raised the firm’s price target on Adtran (ADTN) to $15 from $10 and keeps a Buy rating on the shares. The firm sees an “elevated probability” that Adtran can report better than modeled forecasts and grow into its valuation.